Table 6.
Predictive factors of fair or poor long-term outcome according to the Mayo clinical score in the whole series of 258 patients (including cancer patients) suffering from Bile Duct Cyst (BDC)
| Covariate | Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| Odd Ratio | 95% confidence interval | p value | Odd Ratio | 95% confidence interval | p-value | |
| • Adults (≥15y), Adults vs Children | 3.960 | 1.706–9.192 | 0.0014 | 1.859 | 0.739–4.679 | 0.1878 |
| • Todani BDC subtypes, Type IV-A versus Type I +IV-B | 2.508 | 1.317–4.775 | 0.0051 | 2.075 | 1.025–4.199 | 0.0425 |
| • Prior hepatobiliary surgery, Yes vs No | 3.486 | 1.888–6.435 | <0.0001 | 2.640 | 1.327–5.252 | 0.0057 |
| • Prior cyst-enterostomy, Yes vs No | 4.662 | 1.792–12.129 | 0.0016 | |||
| • Cholangitis, Yes vs No | 2.152 | 1.172–3.949 | 0.0134 | |||
| • Pancreatitis, Yes vs No | 3.620 | 1.241–10.559 | 0.0185 | 2.895 | 0.911–9.200 | 0.0715 |
| • Coexistent biliary disease, Yes vs No | 2.368 | 1.291–4.346 | 0.0054 | |||
| • Coexistent biliary stones, Yes vs No | 2.351 | 1.075–5.138 | 0.0322 | |||
| • Coexistent synchronous cancer, Yes vs No | 8.909 | 3.171–25.032 | <0.0001 | 6.354 | 2.148–18.798 | 0.0008 |
| • MBC involvement, Yes vs No | 2.391 | 1.23–4.651 | 0.0102 | |||
| • Repeat treatment, Yes vs No | 3.920 | 1.212–12.673 | 0.0255 | |||
| • Post-operative complications, Yes vs No | 2.145 | 1.178–3.907 | 0.0126 | |||